---
title: "IceCure Medical Notifies Availability of Brazil ProSense Adoption Update Press Release"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291801568.md"
description: "IceCure Medical announced an update on the adoption of its ProSense cryoablation system in Brazil. Following FDA clearance for early-stage, low-risk breast cancer, management reported increased physician awareness and demand. The device holds ANVISA clearance in Brazil, where commercial procedures are underway. The company is also conducting a 750-patient SIX study to support its focus on breast cancer treatment."
datetime: "2026-07-06T12:13:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291801568.md)
  - [en](https://longbridge.com/en/news/291801568.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291801568.md)
generator: "portal-rs"
---

# IceCure Medical Notifies Availability of Brazil ProSense Adoption Update Press Release

-   IceCure published a July 6, 2026 update flagging rising ProSense cryoablation adoption in Brazil following FDA clearance for early-stage, low-risk breast cancer. \* ProSense holds ANVISA clearance in Brazil; management cited a post-FDA boost in physician awareness and demand. \* Commercial procedures in Brazil are underway; focus includes breast cancer, supported by a 750-patient SIX study now enrolling. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IceCure Medical Ltd. published the original content used to generate this news brief on July 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ICCM.US](https://longbridge.com/en/quote/ICCM.US.md)

## Related News & Research

- [IceCure wins China NMPA approval to market ProSense cryoablation system](https://longbridge.com/en/news/298589959.md)
- [IceCure says West Cancer Center begins enrollment for ChoICE breast cancer cryoablation study](https://longbridge.com/en/news/296489702.md)
- [ISG says Brazilian firms automate digital workplace operations to boost productivity, cut costs](https://longbridge.com/en/news/298591108.md)
- [IceCure adds Adventist Health Glendale as enrolling site for ChoICE breast cancer cryoablation study](https://longbridge.com/en/news/295106064.md)
- [IceCure highlights 5-year ICE3 breast cancer trial showing 3.1% recurrence rate after cryoablation](https://longbridge.com/en/news/295804964.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**